Alpha-V/Beta-3 Integrin, Human, mAb BV3
The monoclonal antibody BV3 recognizes human alpha-V/beta-3 integrin present on human cells.
Integrins are a superfamily of αβ heterodimeric cell-surface adhesion receptors found in many
species. They are expressed on a variety of cells and mediate numerous physiological processes,
including inflammation, migration, adhesion and proliferation. The β3 family consist of 2 members:
αIIbβ3 and αvβ3, which mediate cell-cell and cell-ECM interactions and are important for cellular
migration, regulation of gene expression, cell survival, adhesion and differentiation. All processes
which are involved in tissue development, angiogenesis and thrombosis. Each subunit consist of an
extracellular domain, a single transmembrane segment and a cytoplasmic tail. They connect to the
actin cytoskeleton via adaptor proteins that bind theircytoplasmic tails. Cell matrix adhesions also act
as signaling units by their capacity to organize the actin cytoskeleton and to accumulate various
signaling intermediates. Integrin αvβ3 was originally identified as the vitronectin receptor.
Nevertheless, other ligands include fibrinogen, fibronectin, laminin, thrombospondin, Von Willebrand
factor, tenascin, osteopontin and several forms of collagen. The interactions of integrin αvβ3 to those
ligands is mediated by the RGD (Arg-Gly-Asp) sequence motif present in these proteins. Deregulation
of β3 integrins is involved in e.g. autoimmune diseases, cardiovascular disorders, transplant rejection
and tumorigenesis. In contribution to the latter, integrin αvβ3 contribute by supporting growth of small
(tumor) blood vessels thereby potentiating the metastatic potential. Overexpression of integrin αvβ3
has been demonstrated in various tumors and activated endothelium.
IHC: Tissue sections fixed in Histochoice and blocked with 5% BSA. (Ref.1).
Calculate your ELISA data easily
With the ELISA calculator you can easily calculate ELISA data. Assayfit Pro helps to perform curve fitting. The calculator generates advanced reports, fit graph, fit parameters and goodness of fit are shown.
Latest Hycult Biotech news
- New Human Complement Pathway AssaysWe are very proud of our newly developed human classical and alternative complement pathway assays. They are produced in response to a growing demand for quantitative investigation of complement inhibitors or regulators at lower sample dilutions. This development aims to address the issue of false negative results, enabling more accurate and reliable analysis of complement… Read more: New Human Complement Pathway Assays
- Navigating the pitfalls in complement analysisOur colleague Erik Toonen shared his experience on how to analyze complement at the Complement-based Drug Development Summit in Boston in September 11-13th, 2023. He showed valuable insights on analyzing complements. For accurate complement analysis, it is important that not only the correct technique is used but also that pre-analytical sample handling is performed in… Read more: Navigating the pitfalls in complement analysis
- NEW Human C3d ELISAWe are happy to introduce our new ELISA (cat.# HK3017) designed to detect human C3d. What sets this assay apart is its utilization of a distinctive neo-epitope capture antibody that selectively targets a specific C3d region of the alpha chain, which is not available in other C3 variants. This way it specifically distinguishes C3d from native C3… Read more: NEW Human C3d ELISA